Abstract 2649
Background
Pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC), represents one of the most aggressive malignancies. Lymph node (LN) status is considered as one of the most significant risk factors for survival of PDAC patients, and it is of great importance for making reasonable therapeutic strategies to individual patients. Imaging techniques are widely used in the evaluation of LN status in PDAC patients, however, their application are limited because of the inconsistent sensitivities and specificities findings.
Methods
Gene Set Enrichment Analysis (GSEA) and leading edge analysis were used to analyze the data from The Cancer Genome Atlas (TCGA) on 177 PDAC patients to identify genes associated with LN metastasis. The identified genes with LN metastasis were indexed by Spearman’s rank-correlation test to construct the risk score model. Risk scores were used to predict LN metastasis and overall survival (OS). For validation, we used 80 specimens from patients with PDAC diagnosed at Fudan University Shanghai Cancer Center.
Results
A risk model consisting of three genes (MAPK9, ITGA5, AKT2) was developed. This model could correctly predict the LN metastasis evaluated by receiver operating characteristic (ROC) curves [area under curve (AUC) = 0.668, P = 0.001], and risk score positively associated with the number of metastatic lymph node (NLN; Spearman r = 0.3309, P < 0.0001), especially in the PDAC with greatest dimension ≤ 4 cm and total lymph nodes dissected (TLN) > 12 [AUC = 0.80, P = 0.003; Spearman r for MLN = 0.4237, P = 0.0004; Spearman r for lymph node rate (LNR) = 0.3171, P = 0.0089]. In the set of PDAC patients with TLN > 12, patients with high risk had a worse OS than that with low risk with hazard ratio (HR) of 2.657 (P = 0.0044) for all stage and HR of 2.548 (P = 0.045) for stage I and II. Patients from stage I and stage IIA with high risk scores had a similar OS with stage IIB (median survival = 21.13 months vs. 20.23 months, P = 0.8227). In the validation set, high risk scores could also effectively predict the LN metastasis and poor prognosis in resectable PDAC.
Conclusions
Our findings highlight three-gene signature with effective capacity for identification of PDAC patients with poor prognosis that are likely to suffer from LN metastasis.
Clinical trial identification
Legal entity responsible for the study
Fudan University Shanghai Cancer Center.
Funding
National Science Foundation for Distinguished Young Scholars of China.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract